PNC Financial Services Group
VIR icon

PNC Financial Services Group’s Vir Biotechnology VIR Stock Holding History

PNC Financial Services Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Buy
11,340
+918
+9% +$7.32K ﹤0.01% 2809
2025
Q4 		$62.8K Sell
10,422
-2,421
-19% -$14.4K ﹤0.01% 3082
2025
Q3 		$73.3K Sell
12,843
-316
-2% -$1.62K ﹤0.01% 2992
2025
Q2 		$66.3K Buy
13,159
+2,700
+26% +$14.5K ﹤0.01% 2955
2025
Q1 		$67.8K Buy
10,459
+2,171
+26% +$19.3K ﹤0.01% 2915
2024
Q4 		$60.8K Buy
8,288
+1,999
+32% +$15.8K ﹤0.01% 2982
2024
Q3 		$47.1K Sell
6,289
-3,430
-35% -$29.8K ﹤0.01% 3126
2024
Q2 		$86.5K Sell
9,719
-5,239
-35% -$50.2K ﹤0.01% 2710
2024
Q1 		$152K Buy
14,958
+3,772
+34% +$38.4K ﹤0.01% 2364
2023
Q4 		$113K Buy
11,186
+1,869
+20% +$17.1K ﹤0.01% 2527
2023
Q3 		$87.3K Buy
9,317
+4,656
+100% +$66.4K ﹤0.01% 2656
2023
Q2 		$114K Buy
4,661
+640
+16% +$16.1K ﹤0.01% 2566
2023
Q1 		$93.6K Buy
4,021
+13
+0.3% +$332 ﹤0.01% 2611
2022
Q4 		$101K Buy
4,008
+2,937
+274% +$72K ﹤0.01% 2550
2022
Q3 		$20K Sell
1,071
-3,362
-76% -$85.5K ﹤0.01% 3458
2022
Q2 		$114K Buy
+4,433
New +$103K ﹤0.01% 2477
2020
Q4 		– Sell
-26
Closed -$1K – 4074
2020
Q3 		$1K Buy
+26
New +$1.12K ﹤0.01% 3886
2020
Q2 		– Sell
-216
Closed -$8K – 4065
2020
Q1 		$8K Buy
+216
New +$5.81K ﹤0.01% 3493

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

PNC Financial Services Group's VIR Position: Q1 2026 in Review

PNC Financial Services Group increased its Vir Biotechnology (VIR) stake by 8.8% in Q1 2026, buying an estimated $7.32K and bringing the position to 11,340 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

PNC Financial Services Group first reported a position in VIR in Q1 2020 and has held it in 18 quarters since. The position peaked at $152K in Q1 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • PNC Financial Services Group held 11,340 shares of Vir Biotechnology worth $102K as of Q1 2026.
  • PNC Financial Services Group bought 918 Vir Biotechnology shares in Q1 2026, an estimated $7.32K.
  • Vir Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2809 holding.
  • PNC Financial Services Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 18 quarters since.
  • PNC Financial Services Group's Vir Biotechnology position peaked at $152K in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.